Creates provisions relating to pharmacists' authority to dispense insulin
Summary
HB471 revises Missouri pharmacy law to expressly include the dispensing of an emergency supply of insulin within the “practice of pharmacy” and creates a new section authorizing pharmacists to dispense insulin without a current, valid prescription in limited circumstances. A pharmacist must first make reasonable efforts to contact the prescriber or another responsible healthcare provider, and the patient must either have a recent prescription on record or present proof of one, or the pharmacist must determine that refusing to dispense would endanger the patient’s health or disrupt essential chronic therapy. The emergency supply may not exceed the most recent prescription amount or a standard unit-of-use quantity, and it cannot be dispensed if the prescriber has prohibited emergency refills.
Impact
The bill would amend Chapter 338, RSMo, by repealing and reenacting section 338.010 and adding section 338.740. It expands the statutory definition of pharmacy practice to cover emergency insulin dispensing and directs the State Board of Pharmacy, in consultation with other licensing boards, to adopt procedures and documentation rules for these emergency supplies. The bill also provides civil liability protection for pharmacists, their employers, and original prescribers except in cases of negligence, recklessness, or willful or wanton misconduct, and it places the new authority within the broader regulatory framework governing pharmacy practice and rulemaking.
Sentiment
Based on the bill’s caption and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears supportive and practical, focused on improving patient access to a critical medication. The measure is framed as a patient-safety and continuity-of-care bill, especially for people who rely on insulin for chronic disease management. No recorded opposition is included in the provided context, so there is no documented split in sentiment from the available materials.
Contention
The main policy issue is the balance between access and prescription control. Supporters would likely view the bill as a safeguard against dangerous interruptions in insulin therapy, while potential critics could be concerned about dispensing without a current prescription, the scope of pharmacist discretion, and liability standards. Another possible point of contention is the rulemaking authority given to the Board of Pharmacy and related boards, including the procedures pharmacists must follow and the documentation required when insulin is dispensed under emergency authority.